Tricor and Visual field defect - a phase IV clinical study of FDA data

Summary:

Visual field defect is reported as a side effect among people who take Tricor (fenofibrate), especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months also take Cymbalta, and have Erection problems.

The phase IV clinical study analyzes which people have Visual field defect when taking Tricor. It is created by eHealthMe based on reports of 21,730 people who have side effects when taking Tricor from the FDA, and is updated regularly.

What is Tricor?

Tricor has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 22,641 Tricor users. Check the latest studies of Tricor.

What is Visual field defect?

Visual field defect is found to be associated with 766 drugs and 1,038 conditions by eHealthMe. Check the latest studies of Visual field defect.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

21,730 people reported to have side effects when taking Tricor.
Among them, 24 people (0.11%) have Visual field defect.

Among these 24 people:

How long have people been on Tricor when they have Visual field defect? *

What is the gender of people who have Visual field defect when taking Tricor? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Visual field defect when taking Tricor? *

What are other drugs people take besides Tricor? *

What are other side effects people have besides Visual field defect? *

Stress And Anxiety: 9 people, 37.50%
Blindness Unilateral: 9 people, 37.50%
Optic Ischaemic Neuropathy (optic nerve damage due to lack of blood supply): 9 people, 37.50%
Dyspnea (difficult or laboured breathing): 8 people, 33.33%
Joint Pain: 8 people, 33.33%
Deafness Unilateral: 8 people, 33.33%
Fatigue (feeling of tiredness): 8 people, 33.33%
Memory Loss: 6 people, 25.00%
Vasculitis (inflammation of a blood vessel or blood vessels): 6 people, 25.00%
Personality Change: 6 people, 25.00%

What are the existing conditions these people have? *

Erection Problems: 9 people, 37.50%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 12.50%
Weakness: 1 person, 4.17%
Fungal Infection: 1 person, 4.17%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 4.17%
Cardiac Disorder: 1 person, 4.17%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 4.17%
Coronary Revascularisation: 1 person, 4.17%
Fatigue (feeling of tiredness): 1 person, 4.17%
High Blood Pressure: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Tricor and have Visual field defect?

- Check whether Visual field defect is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tricor:

Tricor (22,641 reports)

Browse all side effects of Tricor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual field defect:

Visual field defect (766 drugs)

Browse all the conditions that are associated with Visual field defect:

Visual field defect (1,038 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Tricor) and Tricor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.